Candriam SCA’s Enviva Inc. EVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-90,871
Closed -$5.46M 896
2022
Q3
$5.46M Buy
90,871
+13,191
+17% +$887K 0.04% 362
2022
Q2
$4.45M Sell
77,680
-3,508
-4% -$264K 0.04% 341
2022
Q1
$6.43M Buy
+81,188
New +$5.93M 0.04% 312
2021
Q4
Sell
-70,001
Closed -$3.79M 878
2021
Q3
$3.79M Buy
70,001
+3,505
+5% +$188K 0.03% 448
2021
Q2
$3.48M Buy
66,496
+38,785
+140% +$1.91M 0.02% 473
2021
Q1
$1.21M Hold
27,711
0.01% 602
2020
Q4
$1.26M Buy
27,711
+8,993
+48% +$393K 0.01% 614
2020
Q3
$754K Buy
18,718
+2,351
+14% +$92.5K 0.01% 656
2020
Q2
$590K Buy
+16,367
New +$544K 0.01% 692

Other funds holding EVA

Candriam SCA's EVA Position: Q4 2022 in Review

Candriam SCA sold out of Enviva Inc. (EVA) in Q4 2022, closing a stake of 90,871 shares — an estimated $5.46M sold.

Candriam SCA first reported a position in EVA in Q2 2020 and held it in 9 quarters. The position peaked at $6.43M in Q1 2022. 185 funds tracked by Wall St. Rank hold EVA as of Q4 2022.

  • Candriam SCA reported no remaining Enviva Inc. position as of Q4 2022 after selling out during the quarter.
  • Candriam SCA sold 90,871 Enviva Inc. shares in Q4 2022, an estimated $5.46M.
  • Candriam SCA first reported a position in Enviva Inc. in Q2 2020 and held it in 9 quarters.
  • Candriam SCA's Enviva Inc. position peaked at $6.43M in Q1 2022.
  • 185 funds tracked by Wall St. Rank held Enviva Inc. as of Q4 2022.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.